Amplifying awareness of cardiac amyloidosis and the need for early recognition

Abstract

Improvements in clinical awareness of cardiac amyloidosis have led to earlier recognition of signs and symptoms, access to diagnostics and a specialist multidisciplinary team. Yet, it remains a life-limiting disease. This editorial discusses cardiac amyloidosis and how nurses can identify ‘red flags’ to facilitate earlier diagnosis.